Status:
COMPLETED
Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
NSA, Collierville, TN, USA
Conditions:
Common Cold
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The primary objective of this study is to determine the effect of an encapsulated juice powder concentrate on the number of days with at least moderate common cold symptoms over winter time.
Detailed Description
Common cold is the most frequent acute illness in industrialised societies. Though it is usually benign, it is a leading cause of absence from work and doctor visits, causing an enormous economic burd...
Eligibility Criteria
Inclusion
- Female or male, 18-65 years of age.
- Able and willing to take the active or placebo capsules over the whole study period.
- Health care professionals with essential patient contact (physicians, nurses, physiotherapists, etc) in Berlin, Germany.
- Written informed consent.
Exclusion
- Known or suspected hypersensitivity or allergy to one of the ingredients of Juice Plus+®.
- Refusal to stop intake of additional vitamin supplements during study.
- Pregnancy or Lactation.
- Alcohol addiction, drug abuse or any other condition considered by the investigator to interfere with study procedures.
- Language limitations regarding interviews and questionnaires.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
543 Patients enrolled
Trial Details
Trial ID
NCT00778648
Start Date
September 1 2008
End Date
July 1 2009
Last Update
October 5 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Social medicine, Epidemiology & Health Economics
Berlin, State of Berlin, Germany, 10117